Published TCIMAIL newest issue No.199
Maximum quantity allowed is 999
Merci de sélectionner la quantité
An Osteogenic Small Compound (TH)
The helioxanthin analogue (TH) (1) is a first osteogenic small compound that was reported by Ohba et al.1) In their reports, 1 not only stimulates osteoblast differentiation of osteoblast precursors, but also enhances bone regeneration in rodent bone defect models.2,3) The osteogenic effects are also observed in mouse and human pluripotent stem cells4,5) as well as human dental pulp stem cells.6) 1 is one of the most promising compound for inducing bone regeneration.
References
- 1)A novel osteogenic helioxanthin-derivative acts in a BMP-dependent manner.
- 2)Enhancement of bone formation ex vivo and in vivo by a helioxanthin-derivative
- 3)Bone healing by sterilizable calcium phosphate tetrapods eluting osteogenic molecules
- 4)Stepwise differentiation of pluripotent stem cells into osteoblasts using four small molecules under serum-free and feeder-free conditions
- 5)Three-dimensional system enabling the maintenance and directed differentiation of pluripotent stem cells under defined conditions
- 6)Bone regeneration by human dental pulp stem cells using a helioxanthin derivative and cell-sheet technology
The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
- D4393
- ZnCl2-TMEDA
- T1051
- 2,2,6,6-Tetramethylpiperidine
- T0147
- N,N,N',N'-Tetramethylethylenediamine (TMEDA)
- I0160
- Isoprene (stabilized with TBC)
- C1948
- Chlorobenzene
掲載されている情報は，ご覧の「TCIメール」発行当時のものです。ご注文の際には最新情報をご覧ください。
また，地域等によって販売製品が異なります。製品詳細ページが表示されない場合は，販売は行っておりませんのでご了承ください。
また，地域等によって販売製品が異なります。製品詳細ページが表示されない場合は，販売は行っておりませんのでご了承ください。